Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

cimetidine

cimetidine
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Tagamet LIQUID, ORAL 300 mg/5 mL      
Tagamet SOLUTION, INTRAVENOUS 150 mg/mL      
Tagamet TABLET, ORAL 200 mg, 300 mg, 400 mg, 800 mg      


Comments:

If H2 blocker prescribed with PPO, discontinue H2 blocker after 48 hours. Exception if GI physician -- check with physician that H2 blocker is not being used for a non-GI use prior to discontinuing.


Automatic IV to PO conversion per IV to oral conversion guidelines. IV to PO Conversion Guidelines

Automatic renal adjustment per guidelines. Renal Adjustment Guidelines See H2-Receptor Blocker Formulary document for renal dosing recommendations.


Last updated: Mar. 1, 2018







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.